Literature DB >> 12947060

Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Roger J Packer1, James G Gurney, Judy A Punyko, Sarah S Donaldson, Peter D Inskip, Marilyn Stovall, Yutaka Yasui, Ann C Mertens, Charles A Sklar, H Stacy Nicholson, Lonnie K Zeltzer, Joseph P Neglia, Leslie L Robison.   

Abstract

PURPOSE: To describe the neurologic and neurosensory deficits in children with brain tumors (BTs), compare incidence of these deficits with that of a sibling control group, and evaluate the factors associated with the development of these deficits. PATIENTS AND METHODS: Detailed questionnaires were completed on 1,607 patients diagnosed between 1970 and 1986 with a primary CNS tumor. Neurosensory and neurologic dysfunctions were assessed and results compared with those of a sibling control group. Medical records on all patients were abstracted, including radiotherapy dose and volume.
RESULTS: Seventeen percent of patients developed neurosensory impairment. Relative to the sibling comparison group, patients surviving BTs were at elevated risk for hearing impairments (relative risk [RR], 17.3; P = <.0001), legal blindness in one or both eyes (RR, 14.8; P = <.0001), cataracts (RR, 11.9; P = <.0001), and double vision (RR, 8.8; P = <.0001). Radiation exposure greater than 50 Gy to the posterior fossa was associated with a higher likelihood of developing any hearing impairment. Coordination and motor control problems were reported in 49% and 26%, respectively, of survivors. Children receiving at least 50 Gy to the frontal brain regions had a moderately elevated risk for motor problems (RR, 2.0; P <.05). Seizure disorders were reported in 25% of patients, including 6.5% who had a late first occurrence. Radiation dose of 30 Gy or more to any cortical segment of the brain was associated with a two-fold elevated risk for a late seizure disorder.
CONCLUSION: Children surviving BTs are at significant risk for both early and late neurologic or neurosensory sequelae. These sequelae need to be prospectively monitored.

Entities:  

Mesh:

Year:  2003        PMID: 12947060     DOI: 10.1200/JCO.2003.01.202

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  122 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

2.  Sleep disturbances in adult survivors of childhood brain tumors.

Authors:  Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

3.  Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life.

Authors:  Michele Montgomery; Sujuan Huang; Cheryl L Cox; Wendy M Leisenring; Kevin C Oeffinger; Melissa M Hudson; Jill Ginsberg; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2010-10-05       Impact factor: 4.442

4.  Risk stratification of medulloblastoma: a paradigm for future childhood brain tumor management strategies.

Authors:  Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

5.  Pediatric high-grade gliomas: survival at what cost?

Authors:  Katherine E Warren
Journal:  Transl Pediatr       Date:  2012-10

Review 6.  Brain tumors in children.

Authors:  Andrew W Walter; Joanne M Hilden
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 7.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

Review 8.  Childhood brain tumors: accomplishments and ongoing challenges.

Authors:  Roger J Packer
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

9.  Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.

Authors:  Ki Woong Sung; Do Hoon Lim; Meong Hi Son; Soo Hyun Lee; Keon Hee Yoo; Hong Hoe Koo; Ji Hye Kim; Yeon-Lim Suh; Yoo Sook Joung; Hyung Jin Shin
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

10.  Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Tara M Brinkman; Nicole J Ullrich; Nan Zhang; Daniel M Green; Lonnie K Zeltzer; Karen M Lommel; Pim Brouwers; Deo Kumar Srivastava; Neelam Jain; Leslie L Robison; Kevin R Krull
Journal:  J Cancer Surviv       Date:  2012-12-08       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.